Skip to main navigation
Fate Therapeutics
0
Primary Menu
Skip to content
About Us
Our Mission
Our Cells of Interest
Management
Board of Directors
Pipeline
Overview
Immuno-Oncology Candidates
Fate-NK100
FT500
Engineered hnCD16iNK
Engineered CAR iT Cell
Immuno-Regulation Candidates
ProTmune
™
ToleraCyte
™
Science
Ex Vivo
Cell Modulation
iPSC Product Platform
ISSCR Annual Meeting and Presentations
ISSCR 2017 Annual Meeting
ISSCR 2016 Annual Meeting
Publications
Collaborations
Join Our Team
Career Opportunities
Vision, Mission, Values
Working at Fate
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
SEC Filings
Annual Reports and Proxies
Corporate Governance
Stock Information
Historic Stock Lookup
Investors FAQs
Contact
Investors
Overview
Press Releases
Events & Presentations
Financial & Filings
Corporate Governance
Stock Information
Investors FAQs
Printed Materials
No documents are currently available to order by mail.